Temperature/pH-Triggered PNIPAM-Based Smart Nanogel System Loaded With Anastrozole Delivery for Application in Cancer Chemotherapy
- 139 Downloads
Thermo and pH-responsive poly-N-isopropylacrylamide (PNIPAM) polymer has gained interest due to microenvironment targeting potential toward cancer cells. Its exceptional potential of the phase transition at body temperature (37°C) makes it biologically relevant for drug delivery and biosensing. The optimum drug loading and particle size with controlled release at a specific site are essential for critical process parameters (CPP). This study investigates the formulation optimization anastrozole (ANST)-loaded PNIPAM nanoparticle (NPs) prepared by solvent evaporation method for pH- and thermo-responsive drug delivery. Box-Behnken design (BBD) was implemented to observe the effect of selected process parameters on quality attributes product including particle size 110.15 nm, zeta potential − 11.02 mV, PDI 0.175, and drug loading 8.35% (DL). The statistical data was found to fit in the quadratic model and p value is less than 0.005. The thermo-responsive behavior of PNIPAM is evaluated on DLS and UV-Visible spectroscopy at elevated temperature to 60°C that has shown increment in turbidity showed aggregation of the nanoparticles. The TEM and AFM revealed the spherical and smooth surface ANST-PNIPAM NPs. The formulation showed the controlled release of ANST for 48 h at pH 7.4 and triggered release at simulated tumor microenvironment pH 5.0. The in vitro cytotoxicity of the formulation is higher than free ANST and shown dose-dependent cell viability. The higher cell uptake was observed by NPs after 12-h incubation in MCF-7 cell lines using confocal microscopy. Apoptotic evaluation of ANST-PNIPAM NPs exhibited 22.67% in comparison to free ANST where 6% was analyzed on the flow cytometer.
KEY WORDSpoly-N-isopropylacrylamide (PNIPAM) pH-sensitive drug release cancer anastrozole
Financial support was from the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, Government of India and Nanomission, India (Grant SR/NM/NS-1123/2016). The NIPER-R communication number is NIPER-R/Communication/062.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 9.Shukla R, et al. Microparticles of diethylcarbamazine citrate for the treatment of lymphatic filariasis. Asian J Chem. 2015;5(85):69047–56.Google Scholar
- 11.Gorain B, Choudhury H, Pandey M, Nair AB, Amin MCIM, Molugulu N, et al. Dendrimer-based nanocarriers in lung Cancer therapy. Nanotechnology-based targeted drug delivery systems for lung cancer: Elsevier. p. 161–92.Google Scholar
- 17.Hao J, Fang X, Zhou Y, Wang J, Guo F, Li F, et al. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. Nanomedicine. 6:683.Google Scholar
- 30.Van der Pol E, Coumans FAW, Grootemaat AE, Gardiner C, Sargent IL, Harrison P, et al. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost. 2014;12(7):1182–92.CrossRefGoogle Scholar
- 41.Emily A, Kristen K, Christin M, Elizabeth I, Donald A, Saber M. Tannic acid coated gold nanorods demonstrate a distinctive form of endosomal uptake and unique distribution within cells. ACS Appl Mater Interfaces. 2013;21(30):331–60.Google Scholar